Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:04 29/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11.37 HKD | +1.16% |
|
-2.07% | -5.01% |
| 04/09 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 03/09 | Simcere Pharmaceutical Group Limited Announces Approval for Marketing of Yingmule in China | CI |
| Market Cap | 372.14Cr 2.92TCr 328.23Cr 310.52Cr 281.39Cr 528.11Cr 36TCr 532.75Cr 3.72TCr 1.43TCr 18TCr 1.4TCr 1.37TCr 59TCr | P/E 2026 * |
14.1x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 352.41Cr 2.76TCr 310.83Cr 294.05Cr 266.47Cr 500.11Cr 34TCr 504.5Cr 3.52TCr 1.36TCr 17TCr 1.32TCr 1.29TCr 55TCr | EV / Sales 2026 * |
2.33x | EV / Sales 2027 * | 2.04x |
| Free-Float |
33.7% | Yield 2026 * |
3.71% | Yield 2027 * | 4.21% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | +1.16% | ||
| 1 week | -2.07% | ||
| Current month | +2.43% | ||
| 1 month | +0.62% | ||
| 3 months | +22.65% | ||
| 6 months | -5.80% | ||
| Current year | -5.01% |
| 1 week | 11.05 |  | 11.73 |
| 1 month | 10.92 | | 12.01 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Other | Chairperson | -30,00,000 | 0.1168% | ||
| 13/07/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/07/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | -2.07% | -8.89% | +77.38% | 367.97Cr | |
| +1.47% | -0.21% | +17.54% | +64.71% | 4.59TCr | |
| +2.89% | +2.52% | +46.81% | +113.64% | 3.7TCr | |
| -1.19% | +3.40% | +23.13% | +99.17% | 1.26TCr | |
| -0.32% | -0.49% | -8.01% | +18.49% | 1.16TCr | |
| -0.19% | 0.00% | +17.65% | +137.44% | 896.77Cr | |
| -3.15% | -2.32% | +35.43% | -18.92% | 719.33Cr | |
| -0.56% | -4.42% | +26.20% | +37.38% | 699.55Cr | |
| +4.98% | -0.35% | +23.83% | +214.24% | 683.72Cr | |
| +0.30% | -4.59% | -50.63% | +1.01% | 492.9Cr | |
| Average | +0.54% | -0.80% | +12.31% | +74.46% | 1.46TCr | |
| Weighted average by Cap. | +1.15% | +0.34% | +22.04% | +80.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150.94Cr 1.18TCr 133.13Cr 125.94Cr 114.13Cr 214.2Cr 14TCr 216.08Cr 1.51TCr 580.98Cr 7.4TCr 566.75Cr 554.4Cr 24TCr | 175.71Cr 1.38TCr 154.98Cr 146.61Cr 132.86Cr 249.35Cr 17TCr 251.54Cr 1.76TCr 676.33Cr 8.61TCr 659.76Cr 645.38Cr 28TCr |
| Net income | 26Cr 201.4Cr 23Cr 21Cr 19Cr 36Cr 2.46TCr 37Cr 256.43Cr 99Cr 1.26TCr 96Cr 94Cr 4.04TCr | 30Cr 238.11Cr 27Cr 25Cr 23Cr 43Cr 2.91TCr 43Cr 303.18Cr 116.82Cr 1.49TCr 113.95Cr 111.47Cr 4.78TCr |
| Net Debt | -20Cr -154.8Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -197.11Cr -76Cr -967.02Cr -74Cr -72Cr -3.11TCr | -14Cr -109.64Cr -12Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -139.6Cr -54Cr -684.89Cr -52Cr -51Cr -2.2TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | HK$11.37 | +1.16% | 34,46,000 |
| 28/26/28 | HK$11.24 | +0.45% | 27,95,000 |
| 25/26/25 | HK$11.19 | -1.76% | 5,06,000 |
| 24/26/24 | HK$11.39 | -2.40% | 35,84,000 |
| 23/26/23 | HK$11.67 | +0.60% | 27,76,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
